Acadian Asset Management »

Rapport Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $43k 1.5k 29.09

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Mastercard Incorporated Cl A (MA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Booking Holdings (BKNG)
JPMorgan Chase & Co. (JPM)
Deutsche Bank A G Namen Akt (DB)
Ubs Group SHS (UBS)
Logitech Intl S A SHS (LOGI)
Broadcom Ord Shs (AVGO)
Telefonaktiebolaget Lm Erics Adr B Sek 10 (ERIC)

View all positions for Acadian Asset Management

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
Sofinnova Ventures
Johnson & Johnson
Vanguard Group
BlackRock
Baker Bros. Advisors
Siren
Trv Gp Vi
Vestal Point Capital
Polar Capital Holdings

View all funds holding Rapport Therapeutics